5 Best Performing Biotech ETFs in 2024
The Putnam BioRevolution ETF (NYSE:SYNB) is designed to pursue long-term capital growth by investing in a carefully curated portfolio of 30-50 stocks.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 3,600,000 | $460,440,000 | 2.57% | ||
2. | 1,456,300 | $186,260,770 | -13% | 0.42% | |
3. | Bronte Capital John Hempton | 262,399 | $39,261,464 | -1% | 3.19% |
4. | 295,900 | $37,845,610 | -25% | 0.01% | |
5. | 195,100 | $24,953,290 | -45% | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 25,512 | $3,227,477 | 0.14% | |
2. | 12,938 | $1,681,958 | 0.6% | |
3. | 11,647 | $1,473,462 | 0.04% | |
4. | 6,414 | $811,435 | 0.08% | |
5. | 4,643 | $587,386 | 0.18% |